BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14499250)

  • 1. C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury.
    Fleming SD; Mastellos D; Karpel-Massler G; Shea-Donohue T; Lambris JD; Tsokos GC
    Clin Immunol; 2003 Sep; 108(3):263-73. PubMed ID: 14499250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
    Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J
    J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade.
    Kusakabe J; Hata K; Tamaki I; Tajima T; Miyauchi H; Wang Y; Nigmet Y; Okamura Y; Kubota T; Tanaka H; Tsuruyama T; Uemoto S
    Transplantation; 2020 Oct; 104(10):2065-2077. PubMed ID: 32384381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5 is required for CD49d expression on neutrophils and VCAM expression on vascular endothelial cells following mesenteric ischemia/reperfusion.
    Fleming SD; Anderson J; Wilson F; Shea-Donohue T; Tsokos GC
    Clin Immunol; 2003 Jan; 106(1):55-64. PubMed ID: 12584052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting the C5-C5a receptor axis.
    Woodruff TM; Nandakumar KS; Tedesco F
    Mol Immunol; 2011 Aug; 48(14):1631-42. PubMed ID: 21549429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.
    Proctor LM; Arumugam TV; Shiels I; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2004 Jun; 142(4):756-64. PubMed ID: 15159277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine.
    Arumugam TV; Shiels IA; Woodruff TM; Reid RC; Fairlie DP; Taylor SM
    J Surg Res; 2002 Apr; 103(2):260-7. PubMed ID: 11922743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex.
    Austen WG; Kyriakides C; Favuzza J; Wang Y; Kobzik L; Moore FD; Hechtman HB
    Surgery; 1999 Aug; 126(2):343-8. PubMed ID: 10455904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
    Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
    J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration.
    Mastellos D; Papadimitriou JC; Franchini S; Tsonis PA; Lambris JD
    J Immunol; 2001 Feb; 166(4):2479-86. PubMed ID: 11160308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane attack complex of complement and neutrophils mediate the injury of acid aspiration.
    Kyriakides C; Austen W; Wang Y; Favuzza J; Kobzik L; Moore FD; Hechtman HB
    J Appl Physiol (1985); 1999 Dec; 87(6):2357-61. PubMed ID: 10601189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils.
    de Vries B; Köhl J; Leclercq WK; Wolfs TG; van Bijnen AA; Heeringa P; Buurman WA
    J Immunol; 2003 Apr; 170(7):3883-9. PubMed ID: 12646657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement depletion protects lupus-prone mice from ischemia-reperfusion-initiated organ injury.
    Ioannou A; Lieberman LA; Dalle Lucca JJ; Tsokos GC
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G283-92. PubMed ID: 23104558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement component C5a mediates hemorrhage-induced intestinal damage.
    Fleming SD; Phillips LM; Lambris JD; Tsokos GC
    J Surg Res; 2008 Dec; 150(2):196-203. PubMed ID: 18639891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration.
    Wu MCL; Lee JD; Ruitenberg MJ; Woodruff TM
    J Immunol; 2020 Nov; 205(10):2834-2839. PubMed ID: 33028618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
    Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
    Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.
    Rehrig S; Fleming SD; Anderson J; Guthridge JM; Rakstang J; McQueen CE; Holers VM; Tsokos GC; Shea-Donohue T
    J Immunol; 2001 Nov; 167(10):5921-7. PubMed ID: 11698469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex.
    Kyriakides C; Austen W; Wang Y; Favuzza J; Kobzik L; Moore FD; Hechtman HB
    Am J Physiol; 1999 Dec; 277(6):C1263-8. PubMed ID: 10600778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of C5aR prevents intestinal mucosal damage and attenuates neutrophil infiltration in local and remote organs.
    Xu DZ; Zaets SB; Chen R; Lu Q; Rajan H; Yang X; Zhang J; Feketova E; Bogdan N; Deitch EA; Cao Y
    Shock; 2009 May; 31(5):493-9. PubMed ID: 18791492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist.
    Sewell DL; Nacewicz B; Liu F; Macvilay S; Erdei A; Lambris JD; Sandor M; Fabry Z
    J Neuroimmunol; 2004 Oct; 155(1-2):55-63. PubMed ID: 15342196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.